Peter Maag - 24 Jun 2021 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Executive Chair, Director
Signature
/s/ Peter Maag
Issuer symbol
CDNA
Transactions as of
24 Jun 2021
Net transactions value
-$715,087
Form type
4
Filing time
25 Jun 2021, 19:54:01 UTC
Previous filing
23 Jun 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $1,981 +314 +0.08% $6.31 372,258 24 Jun 2021 Direct F1
transaction CDNA Common Stock Options Exercise $226,236 +9,291 +2.5% $24.35 381,549 24 Jun 2021 Direct F1
transaction CDNA Common Stock Sale $915,398 -9,605 -2.5% $95.30 371,944 24 Jun 2021 Direct F1, F2
transaction CDNA Common Stock Options Exercise $9,618 +395 +0.11% $24.35 372,339 25 Jun 2021 Direct F1
transaction CDNA Common Stock Sale $37,525 -395 -0.11% $95.00 371,944 25 Jun 2021 Direct F1
holding CDNA Common Stock 1,000 24 Jun 2021 As UTMA custodian for minor child F3
holding CDNA Common Stock 1,000 24 Jun 2021 As UTMA custodian for minor child F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -314 -2.6% $0.000000 11,718 24 Jun 2021 Common Stock 314 $6.31 Direct F1, F4
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -9,291 -13% $0.000000 62,742 24 Jun 2021 Common Stock 9,291 $24.35 Direct F1, F5
transaction CDNA Employee Stock Option (right to buy) Options Exercise $0 -395 -0.63% $0.000000 62,347 25 Jun 2021 Common Stock 395 $24.35 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.00 to $95.76, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F3 Shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F4 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter.
F5 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter.